Jean-Claude do-Rego

694 total citations
20 papers, 575 citations indexed

About

Jean-Claude do-Rego is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Jean-Claude do-Rego has authored 20 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Jean-Claude do-Rego's work include Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (10 papers) and Pain Mechanisms and Treatments (5 papers). Jean-Claude do-Rego is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (10 papers) and Pain Mechanisms and Treatments (5 papers). Jean-Claude do-Rego collaborates with scholars based in France, Poland and Canada. Jean-Claude do-Rego's co-authors include Jean Costentin, Jakub Fichna, Anna Janecka, Hubert Vaudry, Jérôme Leprince, Nicolas Chartrel, Youssef Anouar, Catherine Llorens‐Cortés, Stefan Clerens and Jean‐Claude Beauvillain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Jean-Claude do-Rego

20 papers receiving 565 citations

Peers

Countries citing papers authored by Jean-Claude do-Rego

Since Specialization

Citations

This map shows the geographic impact of Jean-Claude do-Rego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Claude do-Rego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Claude do-Rego more than expected).

Fields of papers citing papers by Jean-Claude do-Rego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Claude do-Rego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Claude do-Rego. The network helps show where Jean-Claude do-Rego may publish in the future.

Co-authorship network of co-authors of Jean-Claude do-Rego

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Claude do-Rego. A scholar is included among the top collaborators of Jean-Claude do-Rego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Claude do-Rego. Jean-Claude do-Rego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Opioid and Cannabinoid System in Food Intake 2016 ·Current Pharmaceutical Design ·(unknown), Jean-Claude do-Rego, Jean‐Luc Do‐Régo, Maria Zubrzycka, Anna Janecka	12
2	P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 2015 ·PLoS Medicine ·(unknown), Chris Young, (unknown), Anna Teti, Paweł Kaliński, (unknown), (unknown), (unknown), Gianluca Tozzi, (unknown), Olivier Wurtz, (unknown), Mikhail Shugay, Jie Tong, David Vaudry, S. Arkle, Jean-Claude do-Rego, Dariusz C. Górecki	51
3	Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-β³-pseudopeptide Agonist 2012 ·Journal of Medicinal Chemistry ·(unknown), Benjamin Lefranc, (unknown), Jean-Claude do-Rego, Adèle Bourmaud, Philippe Chan, (unknown), (unknown), Julien Chuquet, Laure Guilhaudis, Jean A. Boutin, Isabelle Ségalas-Milazzo, Jean Costentin, Hubert Vaudry, (unknown), David Vaudry, Jérôme Leprince	27
4	Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract 2010 ·Regulatory Peptides ·Jakub Fichna, Katarzyna Gach, Renata Perlikowska, (unknown), Jean Jacques Bonnet, Jean-Claude do-Rego, Anna Janecka, Martin Storr	12
5	Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2 2009 ·Bioorganic & Medicinal Chemistry ·Renata Perlikowska, Katarzyna Gach, Jakub Fichna, Géza Tóth, Bogdan Walkowiak, Jean-Claude do-Rego, Anna Janecka	27
6	Novel highly potent μ-opioid receptor antagonist based on endomorphin-2 structure 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jakub Fichna, Jean-Claude do-Rego, Tomasz Janecki, (unknown), Jeroen Poels, Jozef Vanden Broeck, Jean Costentin, Peter W. Schiller, Anna Janecka	10
7	[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity 2007 ·Peptides ·Jakub Fichna, Jean-Claude do-Rego, Nga N. Chung, Jean Costentin, Peter W. Schiller, Anna Janecka	11
8	Synthesis and Characterization of Potent and Selective μ-Opioid Receptor Antagonists, [Dmt, d-2-Nal⁴]endomorphin-1 (Antanal-1) and [Dmt¹, d-2-Nal⁴]endomorphin-2 (Antanal-2) 2007 ·Journal of Medicinal Chemistry ·Jakub Fichna, Jean-Claude do-Rego, Nga N. Chung, Carole Lemieux, Peter W. Schiller, Jeroen Poels, Jozef Vanden Broeck, Jean Costentin, Anna Janecka	37
9	[35S]GTPγS binding stimulated by endomorphin-2 and morphiceptin analogs 2006 ·Biochemical and Biophysical Research Communications ·Jakub Fichna, Jean-Claude do-Rego, Piotr Kossoń, Peter W. Schiller, Jean Costentin, Anna Janecka	6
10	Comparisons between anxiety tests for selection of anxious and non anxious mice 2006 ·Behavioural Brain Research ·Jean-Claude do-Rego, Alice Fialho Viana, (unknown), (unknown), Stela Maris Kuze Rates, Isabelle Leroux‐Nicollet, (unknown)	27
11	Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs 2005 ·Biochemical Pharmacology ·Anna Janecka, Jakub Fichna, R. Kruszyński, Yusuke Sasaki, Akihiro Ambo, Jean Costentin, Jean-Claude do-Rego	25
12	Behavioral effects of urotensin-II centrally administered in mice 2005 ·Psychopharmacology ·Jean-Claude do-Rego, David Chatenet, (unknown), (unknown), (unknown), Jérôme Leprince, Elizabeth Scalbert, Hubert Vaudry, Jean Costentin	47
13	Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments 2005 ·Cognitive Brain Research ·Charles Suaudeau, Jean-Claude do-Rego, Jean Costentin	9
14	Synthesis and biological activity of N-methylated analogs of endomorphin-2 2005 ·Bioorganic & Medicinal Chemistry ·R. Kruszyński, Jakub Fichna, Jean-Claude do-Rego, Tomasz Janecki, Piotr Kossoń, (unknown), Jean Costentin, Anna Janecka	25
15	Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs 2004 ·Biochemical and Biophysical Research Communications ·Jakub Fichna, Jean-Claude do-Rego, Jean Costentin, Nga N. Chung, Peter W. Schiller, Piotr Kossoń, Anna Janecka	34
16	Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position 2004 ·Biochemical Pharmacology ·Jakub Fichna, Jean-Claude do-Rego, Piotr Kossoń, Jean Costentin, Anna Janecka	22
17	Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity 2003 ·Proceedings of the National Academy of Sciences ·Nicolas Chartrel, (unknown), Youssef Anouar, Jérôme Leprince, (unknown), Stefan Clerens, Jean-Claude do-Rego, Frans Vandesande, Catherine Llorens‐Cortés, Jean Costentin, Jean‐Claude Beauvillain, Hubert Vaudry	164
18	Mouse lines differing in sensitivity to β-CCM differ in tasks used for testing antidepressants 2002 ·Pharmacology Biochemistry and Behavior ·Jean-Claude do-Rego, Charles Suaudeau, Georges Chapouthier, Jean Costentin	14
19	Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes 2001 ·Neuroscience Research ·Amadou T. Corera, Jean-Claude do-Rego, Jean Costentin, Jean‐Jacques Bonnet	6
20	Evidence for the Sequential Formation of Two Complexes Between an Uptake Inhibitor, GBR 12783 [1‐[2‐(Diphenylmethoxy)ethyl]‐4‐(3‐Phenyl‐2‐Propenyl)piperazine], and the Neuronal Transporter of Dopamine 1999 ·Journal of Neurochemistry ·Jean-Claude do-Rego, H Hüe, Jean Costentin, Jean‐Jacques Bonnet	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact